Viking Therapeutics (VKTX) Treasury Shares (2014 - 2026)

Viking Therapeutics (VKTX) has 13 years of Treasury Shares data on file, last reported at $30211.0 in Q1 2026.

• For the quarter ending Q4 2023, Treasury Shares changed 0.0% year-over-year to $6.8 million; the trailing twelve-month figure through Dec 2023 stood at $6.8 million (changed 0.0% YoY), and the FY2023 full-year result was $6.8 million, changed 0.0% from the prior year.
• Treasury Shares steadied at $6.8 million in Q4 2023, from $6.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $6.8 million in Q3 2022 to a low of $1.7 million in Q2 2022.
• A 5-year average of $2.2 million and a median of $2.3 million in 2025 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 1097.88% in 2022 and tumbled 98.69% in 2026, its largest moves.
• Tracing VKTX's Treasury Shares over 2 years: stood at $6.8 million in 2022, then changed by 0.0% to $6.8 million in 2023.
• Business Quant data shows VKTX's Treasury Shares at $6.8 million in Q4 2023, $6.8 million in Q3 2023, and $6.8 million in Q2 2023.